CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Shopee hikes capacity in Brazil by 60% in one year, awaits regulation on medicine sales

By Reuters News

By Andre Romani

SAO PAULO, Oct 27 (Reuters) - Shopee, the e-commerce arm of Singapore's Sea SE.N, has opened four more distribution centers in Brazil and increased the area of an existing facility, part of a move that expanded its local capacity by 60% in the past year, it said on Tuesday.

During an event near Sao Paulo, Shopee said it has opened four cross-docking centers in Recife, Rio de Janeiro, Vitoria and Blumenau, and tripled the operational area of its cross-docking facility in Piracicaba.

  • The openings and the Piracicaba expansion added processing capacity for 2.4 million orders per day, Shopee said, without disclosing its total order capacity in Brazil

  • The move brings Shopee's distribution centers in Brazil to 30 -- 25 cross-docking facilities and five fulfillment centers -- up from 16 a year ago

  • Shopee entered Brazil in 2020 and is now one of the leading e-commerce players in the country, competing with Amazon AMZN.O and MercadoLibre MELI.O

  • Shopee will wait for health regulator Anvisa to finalize regulations before potentially allowing pharmacies to sell medications on its platform, said Felipe Lima, director of business development and fulfillment operations

  • A law approved by Congress this year authorized the sale of medications through online marketplaces in Brazil, but Anvisa is still preparing its own regulations on the matter

  • "We have been closely following the regulatory process, including talks with Anvisa, and we believe we still need greater clarity over the legislation before making any move," he said

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.